Preventive health care for older women: Life-style recommendations and new directions

Aging Clinical and Experimental Research

Volumn 12, Issue 2, 2000, Pages 113-131

  Ferrucci, L ^a   Benvenuti, E ^a   Bartali, B ^a   Bandinelli, S ^a   Di Iorio, A ^b   Russo, C R ^c   Lauretani, F ^d  

^a INRCA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Osp S Giovanni Di Dio   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Healthy diet; Older women; Physical activity; Prevention; Women health

Indexed keywords

AGED; AGING; ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; LIFE EXPECTANCY; LIFESTYLE; LONGEVITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUALITY OF LIFE;

EID: 0034046726     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03339898     Document Type: Article

References (178)

1. Verbrugge L.M.: Gender and health: an update on hypotheses and evidence. J. Health Soc. Behav. 26: 156-182, 1985.
2. Deiana L., Ferrucci L., Pes G.M., Carru C., Delitala G., Ganau A., Mariotti S., Nieddu A., Pettinato S., Putzu P., Franceschi C., Baggio G.: AKEntAnnos. The Sardinia Study of extreme longevity. Aging Clin.Exp.Res. 11: 142-149, 1999.
3. Menard A.M., Roger M., Dry J.: Centenarians in France. Rev. Infirm. 42: 28-30, 1992.
4. The Italian Multicentric Study on Centenarians: Epidemiological and socioeconomic aspects of Italian centenarians. Arch. Gerontol. Geriatr. 25: 149-157, 1997.
5. Zheng Z.X., Wang Z.S., Zhu H.M., Yang J.Y., Peng H.Y., Wang L.X., Li J., Jiang X.W.Y.Y.F.: Survey of 160 centenarians in Shanghai. Age Ageing 22: 16-19, 1997.
6. Guralnik J.M., Land K.C., Blazer D., Fillenbaum G.G., Branch L.G.: Educational status and active life expectancy among older blacks and whites. N. Engl. J. Med. 329: 110-116, 1993.
7. Land K.C., Guralnik J.M., Blazer D.G.: Estimating increment-decrement life tables with multiple covariates from panel data: the case of active life expectancy. Demography 31: 297-319, 1994.
8. Strawbridge W.J., Cohen R.D., Shema S.J., Kaplan G.A.: Successful aging: Predictors and associated activities. Am. J. Epidemiol. 144: 135-141, 1996.
9. Branch L.G., Guralnik J.M., Foley D.J., Kohout F.J., Wetle T.T., Ostfeld A., Katz S.: Active life expectancy for 10,000 Caucasian men and women in three communities. J. Gerontol. 46: M145-M150, 1991.
10. Ferrucci L., Guralnik J.M., Simonsik E., Salive M.E., Corti M.C., Langlois J.: Progressive versus catastrophic disability: A longitudinal view of the disablement process. J. Gerontol. 51A: M123-M130, 1996.
11. Hazzard W.H.: The sex differential in longevity. In: Hazzard W.R., Bierman E.L., Blass J.P., Ettinger W.H., Halter J.B. (Eds.), Principles of Geriatric Medicine and Gerontology, McGraw-Hill, Inc., New York, 1994, pp. 37-47.
12. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H.: Menopause and risk of coronary heart disease in women. N. Engl. J. Med. 316: 1105-1110, 1987.
13. Eaker E.D., Chesebro J.H., Sacks F.M., Wenger N.K., Whisnant J.P., Winston M., AHA Staff: Cardiovascular disease in women. Circulation 88: 1999-2009, 1993.
14. German, P.S., Fried L.P.: Prevention and the elderly: public health issues and strategies. Annu. Rev. Public Health 10: 319-332, 1989.
15. Fogel R.W., Costa D.L.: A theory of technophysioevolution, with some implications for forecasting population, health care costs, and pension costs. Demography 34: 49-66, 1997.
16. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W.: Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341: 1097-1105, 1999.
17. Bruning P.F., Bonfrer J.M., Hart A.A., Van Noord P.A., van der Hoeven H., Collette H.J., Battermann J.J., de Jong-Bakker M., Noijen W.J., de Waard F.: Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int. J. Cancer 51: 14-19, 1992.
18. Azevedo A., Ramos E., von Hafe P., Barros H.: Upper-body adiposity and risk of myocardial infarction. J. Cardiovasc. Risk 6: 321-325, 1999.
19. Poehlman E.T., Toth M.J., Fishman P.S., Vaitkevicius P., Gottlieb S.S., Fisher M.L., Fonong T.: Sarcopenia in aging humans; the impact of menopause and disease. J. Gerontol. 50: 73-77, 1995.
20. Evans J.W., Campell W.W.: Sarcopenia and age-related changes in body composition and functional capacity. J. Nutr. 123: 465-468, 1993.
21. Serrano Rios M.: Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 28: 14-17, 1998.
22. Smith S.R., Zachwija J.J.: Visceral adipose tissue: a critical review of intervention strategies. Int. J. Obes. Relat. Metab. Disord. 23: 329-335, 1999.
23. Hegsted D.M., Kritchevsky D.: Diet and serum lipid concentrations: where are we? Am. J. Clin. Nutr. 65: 1893-1896, 1997.
24. Schaefer E.J., Lichtenstein A.H., Lamon-Fava S., Contois J.H., Li Z., Goldin B.R., Rasmussen H., McNamara J.R., Ordovas J.M.: Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am. J. Clin. Nutr. 63: 234-241, 1996.
25. Nordin B.E., Need A.G., Steurer T., Morris H.A., Chatterton B.E., Horowitz M.: Nutrition, osteoporosis, and aging. Ann. N.Y. Acad. Sci. 20: 336-351, 1998.
26. Dawson-Hughes B.: Calcium and vitamin D nutritional needs of elderly women. J. Nutr. 126: 1165S-1167S, 1996.
27. Kaufman K.R., An K.-N., Chao E.Y.S.: A comparison of intersegmental joint dynamics to isokinetic dynamometer measurements. J. Biomech. 28: 1243-1256, 1995.
28. Joshipura K.J., Ascherio A., Manson J.E., Stampfer M.J., Rimm E.B., Speizer F.E., Hennekens C.H., Spiegelman D., Willett W.C.: Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282: 1233-1239, 1999.
29. La Vecchia C., Tavani A.: Fruit and vegetables, and human cancer. EUR J. Cancer Prev. 7: 3-8, 1998.
30. Messina M.J.: Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 70: 439S-450S, 1999.
31. Bidlack W.R., Wang W.: Nutrition requirements of the elderly. In: Morley J.E., Click Z., Rubenstein L.Z. (Eds.), Geriatric Nutrition. Raven Press Ltd, New York, 1995, pp. 25-49.
32. Baghurst P.A., Rohan T.E.: High-fiber diets and reduced risk of breast cancer. Int. J. Cancer 56: 173-176, 1994.
33. Keil U., Liese A., Filipiak B., Swales J.D., Grobbee D.E.: Alcohol, blood pressure and hypertension. Novartis Found. Symp. 216: 125-144, 1998.
34. Criqui M.H.: Do known cardiovascular risk factors mediate the effect of alcohol on cardiovascular disease? Novartis Found. Symp. 216: 159-167, 1998.
35. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E., Hennekens C.H.: A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N. Engl. J. Med. 319: 267-273, 1988.
36. Pahor M., Guralnik J.M., Havlik R.J., Carbonin P.U., Salive M.E., Ferrucci L., Corti M.C., Hennekens C.H.: Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons. J. Am. Geriatr. Soc. 44: 1030-1037, 1996.
37. Scherr P.A., LaCroix A.Z., Wallace R.B., Berkman L., Curb J.D., Cornoni-Huntley J., Evans D.A., Hennekens C.H.: Light to moderate alcohol consumption and mortality in the elderly. J. Am. Geriatr. Soc. 40: 651-657, 1992.
38. Enger S.M., Ross R.K., Paganini-Hill A., Longnecker M.P., Bernestein L.: Alcohol consumption and breast cancer oestrogen and progesteron receptor status. Br. J. Cancer. 79: 1308-1314, 1999.
39. Pierce J.P., Faerber S., Wright F.A., Newman W., Flatt S.W., Kealey S., Rock C.L., Hryniuk W., Greenberg E.R.: Feasibility of a randomized trial of a high vegetable diet to prevent breast cancer recurrence. Nutr. Cancer 28: 282-288, 1997.
40. Buzzard I.M., Faucett C.L., Jeffery R.W., McBane L., McGovern P., Baxter J.S., Shapiro A.C., Blackburn G.L., Chlebowski R.T., Elashoff R.M., Wynder E.L.: Monitoring dietary change in a low-fat diet intervention study: Advantages of using 24-hour dietary recalls vs food records. J. Am. Diet. Assoc. 96: 574-579, 1996.
41. Metz J.A., Kris-Etherton P.M., Morris C.D., Mustad V.A., Stern J.S., Oparil S., Chait A., Haynes R.B., Resnick L.M., Clark S., Hatton D.C., McMahon M., Holcomb S., Snyder G.W., Pi-Sunyer F.X., McCarron D.A.: Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am. J. Clin. Nutr. 66: 373-385, 1997.
42. McGinnis J.M., Foege W.H.: Actual causes of death in the United States. JAMA 270: 2207-2212, 1993.
43. Pearl R.: Tobacco smoking and longevity. Science 87: 216-217, 1938.
44. Wald N.J., Hackshaw A.K.: Cigarette smoking. An epidemiological overview. Br. Med. Bull. 52: 3-11, 1996.
45. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosemberg H.M., Shopland D.R., Thun M-J., Edwards B.K.: Annual report to the nation on the status of cancer, 1973-1996, with special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst. 91: 675-690, 1999.
46. Qualters J.R., Lee N.C., Smith R.A., Aubert R.E.: Breast and cervical surveillance, United States, 1973-1987, Mor. Mortal Wkly Rep. CDC Surveil. Summ. 42: 1-7, 1999.
47. Szyfter K., Banaszewski J., Jaloszynsky P., Pabiszczak M., Szyfter W., Szmeja Z.: Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract. Acta Biochim. Pol. 46: 275-287, 1999.
48. Chow W.H., Devessa S.S., Warren J.L., Fraumeni J.F.J.: Rising incidence of renal cell cancer in the United States. JAMA 281: 1628-1631, 1999.
49. Talamini G., Bassi C., Falconi M., Sartoni N., Pasetto M., Salvia R., Di Francesco V., Frulloni L., Vaona B., Bovo P., Pederzoli P., Cavallini G.: Early detection of pancreatic can-cer following the diagnosis of chronic pancreatitis. Digestion 60: 554-561, 1999.
50. Pinsky J.L., Jette A.M., Branch L.G., Kannel W.B., Feinleib M.: The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am. J. Public Health 80: 1363-1367, 1990.
51. Denke M.A.: Primary prevention of coronary heart disease in postmenopausal women. Am. J. Med. 107: 48S-50S, 1999.
52. Fruzzetti F.: Hemostatic effects of smoking and oral contraceptive use. Am. J. Obstet. Gynecol. 180: S369-S374, 1999.
53. Cooper G.S., Sandler D.P., Bohlig M.: Active and passive smoking and the occurrence of natural menopause. Epidemiology 10: 771-773, 1999.
54. Christen W.G., Manson J.E., Seddon J.M., Glynn R.J., Buring J.F., Rosner B., Hennekens C.H.: A prospective study of cigarette smoking and risk of cataract in men. JAMA 268: 989-993, 1992.
55. Spangler J.G.: Smoking and hormone-related disorders. Prim. Care 26: 499-511, 1999.
56. Sontag S., Graham D.Y., Belsito A., Weiss J., Farley A., Grunt R., Cohen N., Kinnear D., Davis W., Archambault A., Achord J., Thayer W., Gillies R., Sidov J., Sabesin S.M., Dyck W., Fleshier B., Cleator I., Wenger J., Opekun A. Jr: Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N. Engl. J. Med. 311: 689-693, 1984.
57. Ferrucci L., Izmirlian G., Leveille S., Phillips C.L., Corti M.C., Brock D.B., Guralnik J.M.: Smoking, physical activity, and active life expectancy. Am. J. Epidemiol. 149: 645-653, 1999.
58. Kumar P.R., Kumar N.V.: Effect of cigarette smoking on muscle strength of flexibility of athletes. Indian J. Exp. Biol. 36: 1144-1146, 1998.
59. Vazquez F.L., Becona E.: Treatment of major depression associated with smoking cessation. Acta Psychiatr. Scand. 98: 507-508, 1998.
60. Moller A.M., Tonnesen H.: Group therapy and smoking cessation. Ugeskr. Laeger 161: 4987-4988, 1999.
61. Kunze U., Schmeiser-Rieder A., Schoberberger R.: European Medical Association smoking or Health (EMASH) consensus on smoking cessation: guidelines for physicians. Soz. Praventivmed. 43: 167-172, 1999.
62. Bouchard C., Shephard R.J., Stephens T., Sutton J.R., McPherson B.D.: Exercise, fitness, and health: the consensus statement. In: Exercise, fitness, and health: a consensus of current knowledge. Human Kinetics. Champaign, III., 1990. pp. 3-28.
63. Skelton D.A., Young A., Greig C.A.: Muscle function of women aged 65-89 years meeting two sets of health criteria. Aging Clin. Exp. Res. 9: 106-111, 1997.
64. Bennett K.M.: Gender and longitudinal changes in physical activities in later life. Age Ageing 27: 24-28, 1998.
65. Rutherford O.M.: The role of exercise in prevention of osteoporosis. Physiotherapy 76: 522-526, 1990.
66. Kano K.: Relationship between exercise and bone mineral density among over 5000 women aged 40 years and above. J. Epidemiol. 8: 28-32, 1998.
67. Bassey E.J., Hall M.R.P.: Exercise for elderly people. Exercise and Health 51-58, 1985.
68. Campbell A.J., Robertson M.C., Gardner M.M., Norton R.N., Tilyard M.W.: Randomised controlled trial of a gener al practice program of home based exercise to prevent falls in elderly women. BMJ 315: 1065-1067, 1997.
69. Callaman L.E., Rao J., Boutaugh M.: Arthritis and women s health: prevalence, impact, and prevention. Am. J. Prev. Med. 12: 401-409, 1996.
70. Seals D.R., Stevenson E.T., Jones P.P., DeSouza C.A., Tanaka H.: Lack of age-associated elevations in 24-h systolic and pulse pressures in women who exercise regularly. Am. J. Physiol. 277: H947-H955, 1999.
71. Ishikawa K., Ohta T., Zhang J., Hashimoto S., Tanaka H.: Influence of age and gender on exercise training-induced blood pressure reduction in systemic hypertension. Am. J. Cardiol. 84: 192-196, 1999.
72. Knight S., Bermingham M.A., Mahajan D.: Regular non-vigorous physical activity and cholesterol levels in the elderly. Gerontology 45: 213-219, 1999.
73. Visser M., Launer L.J., Deurenberg P., Deeg D.J.H.: Total and sports activity in older men and women: relation with body fat distribution. Am. J. Epidemiol. 145: 752-761, 1997.
74. Thompson R.F., Crist D.M., Marsh M., Rosenthal M.: Effects of physical exercise for elderly patients with physical impairments. J. Am. Geriatr. Soc. 36: 130-135, 1988.
75. Krebs D.E., Jette A.M., Assermann S.F.: Moderate exercise improves gait stability in disabled elders. Arch. Phys. Med. Rehabil. 79: 1489-1495, 1998.
76. Shephard R.J.: The scientific basis of exercise prescribing for the very old. J. Am. Geriatr. Soc. 38: 62-70, 1990.
77. Leitzmann M.F., Rimm E.B., Willett W.C., Spiegelman D., Grodstein F., Syampfer M.J., Colditz G.A., Giovannucci E.: Recreational physical activity and the risk of cholecystectomy in women. N. Engl. J. Med. 341: 777-784, 1999.
78. Colditz G.A., Manson J.E., Hankinson S.E.: The nurses health study: 20 year contribution to the understanding of health among women. J. Women's Health 6: 49-62, 1997.
79. Martinez M.E., Giovannucci E., Spiegelman D., Hunter D.J., Willett W.C., Colditz G A.: Leisure-time physical activity, body size, and colon cancer in women. J. Natl. Cancer Inst. 89: 948-955, 1997.
80. Young A., Dinan S.: Fitness for older people. BMJ 309: 331-333, 1994.
81. Skelton D.: Exercise for healthy ageing. Research into Ageing, London, 1994.
82. Nelson M.E., Wernick S.: Strong women stay young. Bantan Books, New York, 1997, pp. 1-276.
83. Westcott W.L., Baechle T.R.: Building an effective training program. In: Strength training past 50. Eds. USA, Human Kinetics, 1998, pp. 129-149.
84. Dinan S., Sharp C.: Fitness for life. Judy Piatkus Ltd, London, 1996.
85. Skelton D.A., Young A., Greig C.A., Malbut K.E.: Effects of resistance training on strength, power, and selected functional abilities of women aged 75 and older. J. Am. Geriatr. Soc. 43: 1081-1087, 1995.
86. Barrett-Connor E.: Postmenopausal estrogen and prevention bias. Ann. Intern. Med. 115: 455-456, 1991.
87. Harris R.B., Laws A., Reddy V.M., King A., Haskell W.L.: Are women using postmenopausal estrogens? A community survey. Am. J. Public Health 80: 1266-1268, 1990.
88. Matthews K.A., Kuller L.H., Wing R.R., Meilahn E.N., Plantinga P.: Prior use of estrogen replacement therapy: are users healthier than nonusers. Am. J. Epidemiol. 143: 971-978, 1996.
89. Colditz G.A.: Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. 90: 814-823, 1998.
90. Trichopoulis D., MacMahon B., Cole P.: Menopause and breast cancer risk. J. Natl. Cancer Inst. 48: 605-613, 1972.
91. Thomas H.V., Reeves G.K., Key T.J.: Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 8: 922-928, 1997.
92. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,702 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997.
93. Rose P.G.: Endometrial carcinoma. N. Engl. J. Med. 335: 640-649, 1996.
94. Grady D., Ernster V.L.: Hormone replacement therapy and endometrial cancer: are current regimens safe? J. Natl. Cancer Inst. 89: 1088-1089, 1997.
95. Hebert-Croteau N.: A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol. Biomarkers Prev. 7: 653-659, 1998.
96. Marcantonio E.R., Goldman L., Mangione C.M., Ludwig L.E., Muraca B., Haslauer C.M., Donaldson M.C., Whittemore A.D., Sugarbaker D.J., Poss R., Haas S., Cook E.F., Orav E.J., Lee T.H.: A clinical predition rule for delirium after elective noncardiac surgery. JAMA 271: 134-139, 1994.
97. Rodriguez C., Calle E.E., Coates R.J., Miracle-McMahill H.L., Thun M.J., Healt C.W.: Estrogen replacement therapy and fatal ovarian cancer. Am. J. Epidemiol. 141: 828-835, 1995.
98. Stampfer M.J., Colditz G.A.: Estrogen replacement therapy and coronary heart disease : A quantitative assessment of the epidemiologic evidence, Prev. Med. 20: 47-63, 1991.
99. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., Ernster V.L., Cummings S.R.: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117: 1016-1037, 1992.
100. Grodstein F., Stampfer M.J., Manson J.A., Colditz G.A., Willett W.C., Rosner B., Speizer F.E., Hennekens C.H.: Post-menopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335: 453-461, 1996.
101. Ettinger B., Friedman G.D., Bush T., Quesenberry C.P. Jr.: Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol. 87: 6-12, 1996.
102. Criqui M.H., Suarez L., Barrrett Connor E., McPhillips J., Wingard D.L., Garland C.: Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am. J. Epidemiol. 128: 606-614, 1988.
103. Walsh B.W., Shiff I., Rosner B., Greenberg L., Ravnihar V., Sacks P.M.: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 17: 1196-1204, 1991.
104. Lobo R.A., Pickar J.H., Wild R.A., Walsh B., Hirvonen E.: Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet. Gynecol. 84: 987-995, 1994.
105. Medical Research Council's General Practice Research Framework. Randomized comparison of estrogen us estrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ 312: 473-478, 1996.
106. Lieberman E.H., Gerhard M.D., Uehata A., Walsh B.W., Selwyn A.P., Ganz P., Yeung A.C., Creager M.A.: Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121: 936-941, 1994.
107. Giraud G.D., Morton M.J., Wilson R.A., Burry K.A., Speroff L.: Effects of estrogen and progestin on aortic size and compliance in postmenopausal women. Am. J. Obstet. Gynecol. 174: 1708-1717, 1996.
108. Sullivan J.M.: Coronary arteriography in estrogen-treated postmenopausal women. Prog. Cardiovasc. Dis. 38: 211-222, 1995.
109. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., Collins P.: Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342: 133-136, 1993.
110. Holvoet P., Collen D.: Oxidation of low density lipoprotein in the pathogenesis of atherosclerosis. Atherosclerosis 137: S33-S38, 1998.
111. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E.: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613, 1998.
112. Jick H., Derby L.E., Myers M.J., Vasilakis C., Newton K.M.: Risk of hospital admission of idiopathic venous thromboembolism among users of postmenopausal oestrogen. Lancet 348: 981-983, 1996.
113. Daly E., Vesey M.P., Hawkins M.M., Carson J.L., Giugh P., Marsh S.: Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977-980, 1996.
114. The Writing Group for the PEPI Trial: Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 276: 1389-1396, 1996.
115. Speroff L., Rowan J., Symons J., Genent H., Wilborb W., Clements K.M.: The comparative effect on bone density, endometrium, and lipids of continous hormones as replacement therapy (CHART study). A randomized controlled trial. JAMA 276: 1397-1403, 1996.
116. Cauley J.A., Seeley D.G., Ensrud K., Ettinger B., Black D., Cummings S.R.: Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 122: 9-16, 1995.
117. Felson D.T., Zhang Y., Hannan M.T., Kiel O.P., Wilson P.W., Anderson J.J.: The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med. 329: 1141-1146, 1993.
118. Schnitzer T., Bone H.G., Crepaldi G., Adami S., McClung M., Kiel D., Felsenberg D., Recker R.R., Tonino R.P., Roux C., Pinchera A., Foldes A.J., Greenspan S.L., Levine M.A., Emkey R., Santora II A.C., Kaur A., Thompson D.E., Yates J., and Orloff J.J. for the Alendronate Once Weekly Study Group: Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clin. Exp. Res. 12: 1-12, 2000.
119. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G., Brinker J.A., Clements K.M.: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopeusal women. Circulation 89: 52-60, 1994.
120. Sherwin B.B.: The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72: 336-343, 1997.
121. Hahn R.: Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am. J. Obstet. Gynecol. 161: 1854-1858, 1989.
122. Newton K.M., LaCroix A.Z., Leveille S.G., Rutter C., Keenan N.L., Anderson L.A.: Women's beliefs and decision about hormone replacement therapy. J. Women's Health 6: 459-465, 1997.
123. O'Sullivan A.J., Crampton L.J., Freund J., Ho K.K.Y.: The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J. Clin. Invest. 102: 1035-1040, 1998.
124. Paganini-Hill A., Henderson V.W.: Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140: 256-261, 1999.
125. Henderson V.W., Paganini-Hill A., Emanual C.K., Dunn M.E., Buckwalter J.G.: Estrogen replacement therapy in older women: comparison between Alzheimer's disease cases and non-demented control subjects. Arch. Neural. 51: 896-900, 1994.
126. Tang M-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R.: Effect of oestrogen dur ing menopause on risk and age at onset of Alzheimer's disease. Lancet 348: 429-432, 1996.
127. Barrett-Connor E., Kirtz-Silverstein D.: Estrogen replacement therapy and cognitive function in older women. JAMA 269: 2637-2641, 1993.
128. Phillips S.M., Sherwin B.B.: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485-495, 1992.
129. Parker M.G., Arbuckle N., Dauvois S., Danielian P., White R.: Structure and function of the estrogen receptor. Ann. N. Y. Acad. Sci. 684: 119-126, 1993.
130. Jordan V.C.: Antiestrogenic action of Raloxifene and Tamoxifen: today and tomorrow. J. Natl. Cancer Inst. 90: 967-971, 1998.
131. Fisher B., Powles T.J., Pritchard K.J.: Tamoxifen for prevention of breast cancer. Eur. J. Cancer 36: 142-150, 2000.
132. Powles T., Eeles R., Ashley S., Easton D., Chang J., Dowsett M., Tidy A., Viggers J., Davey J.: Interim analyses of the incidence of breast cancer in the Royal Marsden Hospital. Tamoxifen randomized chemoprevention trial. Lancet 352: 98-101, 1998.
133. Love R.R., Mazess R., Tormey D.C., Barden H.S., Newcomb P.A., Jordan V.C.: Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for a least two years. Breast Cancer Res. Treat. 12: 297-302, 1998.
134. Turken S., Siris E., Selden D., Flaster E., Hyman G., Linday R.: Effects of tamoxifen on spinal bone density in women with breast cancer. J. Natl. Cancer Inst. 81: 1086-1088, 1989.
135. MacMahon B.: Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist. Semin. Oncol. 24: 122-139, 1999.
136. Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravou A.C., Shah A.S., Huster W.J., Draper M., Christiansen C.: Effects of Raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337: 1641-1647, 1997.
137. McNeil C.: In search of the perfect SERM: beyond Tamoxifen and Raloxifene. J. Natl. Cancer Inst. 90: 956-957, 1998.
138. The Women's Health Initiative Study Group: Design of the Women's Health Initiative Clinical Trial and Observational Study. Control. Clin. Trials 19: 61-109, 1998.
139. Van Dijck J.A., Broeders M.J., Verbeek A.L.: Mammographic screening in older women. Is it worthwhile? Drugs Aging 10: 69-79, 1997.
140. Hansen J.: Common cancer in the elderly. Drugs Aging 13: 467-478, 1998.
141. Landis S.H., Murray T., Bolden S., Wingo P.A.: Cancer statistics. CA Cancer J. Clin. 49: 8-31, 1999.
142. Feuer E.J., Wun L.M., Boring C.C.: The lifetime risk of de veloping breast cancer. J. Natl. Cancer Inst. 85: 892-897, 1993.
143. Tabar L., Fageberg G., Duffy S.W.: Update of the Swedish two-county program of mammographic screening for breast cancer. Radial. Clin. North Am. 30: 187-210, 1992.
144. Tabar L., Fageberg G., Day N.E.: What is the optimum interval between mammographie screening examination? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br. J. Cancer 55: 547-551. 1987.
145. Miller A.B., Baines C.J., To T.: Canadian National Breast Screening Study 2: Breast cancer detection and death rates among women aged 50 to 59 years. Can. Med. Assoc. J. 147: 1477-1488, 1992.
146. Kerlikowske K., Grady D., Barclay J.: Effect of age, breast density, and family history on the sensitivity of first screening mammographic. JAMA 276: 33-38, 1996.
147. Costanza M.E.: Breast cancer screening in older women: overview. J. Gerontol. 47 (Special Issue): 1-3, 1992.
148. Screening recommendations of the forum panel. J. Gerontol. 47 (Special Issue): 5, 1992.
149. Katz A.: Cervical cancer screening. Can. Fam. Physician 44P: 1661-1665, 1998.
150. Burk J.R., Lehman H.F., Wolf F.S.: Inadequacy of Papanicolau smears in the detection of endometrial cancer. N. Engl. J. Med. 291: 191-192, 1974.
151. Koss L.G., Schreiber K., Oberlander S.G., Moussoris N.F., Lesser M.: Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet. Gynecol. 64: 1-11, 1984.
152. Smith L.H., Oi R.H.: Detection of malignant ovarian neoplasms: a review of a literature: I. Detection of the patient at risk; clinical radiological and cytological detection. Obstet. Gynecol. Surv. 39: 313-328, 1984.
153. Campbell S., Bhan V.: Transabdominal ultrasound screening for early ovarian cancer. BMJ 299: 1363-1367, 1989.
154. Niloff J.M., Knapp R.C., Schaetzl E., Reynolds C., Bast R.C. Jr.: CA125 antigen levels in obstetric and gynecologic patients. Obstet. Gynecol. 64: 703-707, 1984.
155. Ries L.A.G., Kosary C.L., Hankey B.F., Miller B.A., Edwards B.K.: SEER cancer statistics Review, 1973-1994. National Cancer Institute. NIH PUB. NO. 97-2789. Bethesda, MD, 1997.
156. Ahsan H., Neugut A.I., Garbowsi G.C.: Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann. Intern. Med. 128: 900-905, 1998.
157. Kewenter J., Bjork S., Haglinc E.: Screening and rescreening of colorectal cancer: controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 62: 645-651, 1999.
158. Hardcastle J.D., Thomas W.M., Chamberlain J.: Randomized, controlled trial of faecal occult blood screening for colorectal cancer, results for first 107,349 subjects. Lancet 1: 1160-1164, 1989.
159. Kronborg O., Fenger C., Sondergaard O.: Initial mass screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Funen in Denmark. J. Gastroenterol. 22: 677-686, 1987.
160. Kronborg O., Fenger C., Olsen J.: Repeated screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Funen Denmark. Scand. J. Gastroenterol. 24: 599-606, 1989.
161. Polo-Kantola P., Erkkola R., Helenius H., Irjala K., Polo O.: When does estrogen replacement therapy improve sleep quality? Am. J. Obstet. Gynecol. 178: 1002-1009, 1998.
162. Keefe D.L., Watson R., Naftolin F.: Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 6: 196-200, 1999.
163. Wright K.P., Badia P.: Effects of menstrual cycle phase and oral contraceptives on alertness, cognitive performance, and circadian rhythms during sleep deprivation. Behav. Brain Res. 103: 185-194, 1999.
164. Brzezinski A. "Melatonin replacement therapy" for postmenopausal women: is it justified? Menopause 5: 60-64, 1998.
165. Gentili A., Edinger J.D.: Sleep disorder in older people. Aging Clin. Exp. Res. 11: 137-141, 1999.
166. Morin C.M., Colecchi C., Stone J., Sood R., Brink D.: Behavioral and pharmacological therapies for late-life insomnia. JAMA 281: 991-999, 1999.
167. Lewis-Hall F.C., Wilson M.G., Tepner R.G., Koke S.C.: Fluoxetine us tricyclic antidepressant in women with major depressive disorder. J. Women's Health 6: 337-343, 1997.
168. Prigerson H.G., Maciejewski P.K., Rosenheck R.A.: The effects of marital dissolution and marital quality on health and health service use among women. Med. Care 37: 858-873, 1999.
169. Cochran D.L., Brown D.R., McGregor K.C.: Racial differences in the multiple social roles of older women: implications for depressive symptoms. Gerontologist 39: 465-472, 1999.
170. Bhatia S.C., Bhatia S.K.: Depression in women: diagnostic and treatment considerations. Am. Fam. Physician 60: 234, 1999.
171. Whooley M.A., Kip K.E., Cauley J.A., Ensrud K.E., Nevitt M.C., Browner W.S.: Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 8: 484-490, 1999.
172. Penninx B.W.J.H., Guralnik J.M., Ferrucci L., Simonsick E.M., Deeg D., Wallace R.B.: Depressive symptoms and physical decline in community-dwelling older persons. JAMA 279: 1720-1726, 1999.
173. Carranza-Lira S., Valentino-Figueroa M.L.: Estrogen therapy for depression in postmenopausal women. Int. J. Gynaecol. Obstet. 65: 35-38, 1999.
174. Burt V.K., Altshuler L.L., Rasgon N.: Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. Harv. Rev. Psychiatry 6: 121-132, 1998.
175. Coope J.: Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 23: 159-168, 1996.
176. Reynolds C.F. III, Kupfer D.J.: Depression and aging: a look to the future. Psychiatr. Serv. 50: 1167-1172, 1999.
177. Koening H.G.: Late-life depression: how to treat patients with comorbid chronic illness. Geriatrics 54: 56-61, 1999.
178. Doris A., Ebmeier K., Shajahan P.: Depressive illness. Lancet 354: 1369-1375, 1999.